These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 10732662)

  • 1. Clozapine in the treatment of neuroleptic-induced blepharospasm: a report of 4 cases.
    Levin H; Reddy R
    J Clin Psychiatry; 2000 Feb; 61(2):140-3. PubMed ID: 10732662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clozapine-induced tardive dystonia (blepharospasm).
    Duggal HS; Mendhekar DN
    J Neuropsychiatry Clin Neurosci; 2007; 19(1):86-7. PubMed ID: 17308236
    [No Abstract]   [Full Text] [Related]  

  • 3. Clozapine treatment of psychosis in patients with tardive dystonia: report of three cases.
    Friedman JH
    Mov Disord; 1994 May; 9(3):321-4. PubMed ID: 7913739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients.
    Spivak B; Mester R; Abesgaus J; Wittenberg N; Adlersberg S; Gonen N; Weizman A
    J Clin Psychiatry; 1997 Jul; 58(7):318-22. PubMed ID: 9269253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clozapine and obsessions in patients with recent-onset schizophrenia and other psychotic disorders.
    de Haan L; Linszen DH; Gorsira R
    J Clin Psychiatry; 1999 Jun; 60(6):364-5. PubMed ID: 10401913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Switching clozapine responders to olanzapine.
    Littrell KH; Johnson CG; Hilligoss NM; Peabody CD; Littrell SH
    J Clin Psychiatry; 2000 Dec; 61(12):912-5. PubMed ID: 11206595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clozapine withdrawal-emergent dystonias and dyskinesias: a case series.
    Ahmed S; Chengappa KN; Naidu VR; Baker RW; Parepally H; Schooler NR
    J Clin Psychiatry; 1998 Sep; 59(9):472-7. PubMed ID: 9771818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of stringent criteria on eligibility for clozapine among public mental health clients.
    Juarez-Reyes MG; Shumway M; Battle C; Bacchetti P; Hansen MS; Hargreaves WA
    Psychiatr Serv; 1995 Aug; 46(8):801-6. PubMed ID: 7583481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjunctive loxapine in a clozapine-resistant cohort of schizophrenic patients.
    Mowerman S; Siris SG
    Ann Clin Psychiatry; 1996 Dec; 8(4):193-7. PubMed ID: 8986313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of sudden clozapine discontinuation on management of schizophrenic patients: A retrospective controlled study.
    Miodownik C; Lerner V; Kibari A; Toder D; Cohen H
    J Clin Psychiatry; 2006 Aug; 67(8):1204-8. PubMed ID: 16965197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ziprasidone augmentation of clozapine in 11 patients.
    Kaye NS
    J Clin Psychiatry; 2003 Feb; 64(2):215-6. PubMed ID: 12633133
    [No Abstract]   [Full Text] [Related]  

  • 12. [Risperidone after clozapine in therapy refractory schizoaffective psychosis--a case report].
    Konrad C; Schormair C; Eikelmann B; Telger K
    Psychiatr Prax; 1997 Mar; 24(2):88-9. PubMed ID: 9190618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug treatment of schizophrenic psychoses in puerperium].
    Olbrich HM; Martin P
    Nervenarzt; 1994 Jul; 65(7):482-5. PubMed ID: 7800093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment outcome with clozapine in tardive dyskinesia, neuroleptic sensitivity, and treatment-resistant psychosis.
    Small JG; Milstein V; Marhenke JD; Hall DD; Kellams JJ
    J Clin Psychiatry; 1987 Jul; 48(7):263-7. PubMed ID: 2885310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison.
    Kane JM; Marder SR; Schooler NR; Wirshing WC; Umbricht D; Baker RW; Wirshing DA; Safferman A; Ganguli R; McMeniman M; Borenstein M
    Arch Gen Psychiatry; 2001 Oct; 58(10):965-72. PubMed ID: 11576036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clozapine for blepharospasm, obsessive-compulsive symptoms, and psychotic symptoms in a patient of old brain infarction.
    Sun CH; Lu CH; Huang TL
    Clin Neuropharmacol; 2006; 29(6):368-70. PubMed ID: 17095902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of clozapine on tardive dyskinesia.
    Lieberman JA; Saltz BL; Johns CA; Pollack S; Borenstein M; Kane J
    Br J Psychiatry; 1991 Apr; 158():503-10. PubMed ID: 1675900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of work outcome in neuroleptic-resistant schizophrenia and schizoaffective disorder: cognitive impairment and clozapine treatment.
    Kaneda Y; Jayathilak K; Meltzer H
    Psychiatry Res; 2010 Jun; 178(1):57-62. PubMed ID: 20452677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroleptic-induced emesis: a new indication for clozapine?
    Bustillo JR; Buchanan RW
    Biol Psychiatry; 1995 Aug; 38(3):194-5. PubMed ID: 7578665
    [No Abstract]   [Full Text] [Related]  

  • 20. [Psychoses, mood, suicidal tendencies and clozapine].
    Llorca PM; Lançon C; Reine G
    Encephale; 1997; 23(6):431-6. PubMed ID: 9488925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.